Anti-TFPI Therapeutic Antibody (Concizumab)
Recombinant humanized antibody expressed in CHO binding to human TFPI. Concizumab is a monoclonal IgG4 antibody (mAb) that binds to the Kunitz-type protease inhibitor (KPI) 2 domain of TFPI thereby blocking the interaction of this domain with the active site of FXa.
| Supplier | Creative Biolabs |
|---|---|
| Product # | TAB-734 |
| Pricing | Inquiry |
| Host | undefined |
| Target | TFPI |
| Species Reactivity | Human |
| Type | IgG4 - kappa |
| Applications | ELISA, IP, FC, FuncS, Neut, IF, WB, PK |
| Storage | Store at -20°C. Avoid multiple freeze/thaw cycles. |